MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcard.2024.132468

Медицинская библиотека · International journal of cardiology · 2024

Impact of cardiac conduction disease in patients with cardiac amyloidosis: A national retrospective cohort study.

Lopez Jose, Duarte Gustavo, Mark Justin D, Vergara Sanchez Carlos, De Camps Martinez Elmer R, Black Ann Lowery, Perez Arturo, Zachariah Ashvin, Elshazly Mohamed, Colombo Rosario A, Losiniecki Fergie, Chait Robert, Jimenez Marcello, Baez-Escudero Jose

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

There is a paucity of data regarding the impact of cardiac conduction disease (CD) on clinical outcomes in patients with cardiac amyloidosis (CA).

METHODS

The National Inpatient Sample (NIS) was queried to identify all CA admissions and those with CD using ICD-10 codes from 2016 to 2019. We explored baseline characteristics and used multivariate logistic regression to assess the association between CD and several clinical outcomes during index admission; a p-value of <0.05 was significant. Propensity score matching (PSM) was performed to validate our results.

RESULTS

A total of 12,185 patients with CA were identified. Of these, 920 (7.6 %) had CD. The median age of the sample was 72 years (IQR: 64-80). After multivariate adjustment and PSM, the presence of CD in CA was associated with higher odds of ventricular arrhythmias (VA) (aOR = 2.97, 95 % CI 1.78-4.96, p < 0.001), syncope (aOR = 3.44, 95 % CI 1.51-7.83, p = 0.003), and cardiovascular implantable electronic device (CIED) implantation (aOR = 12.86, 95 % CI 5.50-30.04, p < 0.001) but not with sudden cardiac arrest (p = 0.092), acute heart failure (p = 0.060), all-cause in-hospital mortality (p = 0.384), and non-routine discharge in patients admitted for CA (p = 0.271).

CONCLUSIONS

Although CD was not associated with all-cause in-hospital mortality, there was a significant association with VAs and syncope. Syncope is associated with worse survival in patients with CA. Further studies that prospectively follow patients are needed to determine the true effect of cardiac CD on mortality in patients with CA.

Для цитирования: Lopez Jose, Duarte Gustavo, Mark Justin D, Vergara Sanchez Carlos, De Camps Martinez Elmer R, Black Ann Lowery, Perez Arturo, Zachariah Ashvin, Elshazly Mohamed, Colombo Rosario A, Losiniecki Fergie, Chait Robert, Jimenez Marcello, Baez-Escudero Jose. Impact of cardiac conduction disease in patients with cardiac amyloidosis: A national retrospective cohort study.. International journal of cardiology. 2024. DOI: 10.1016/j.ijcard.2024.132468.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.